Dabigatran Etexilate-Reference-Cited by-同舟云学术

Dabigatran Etexilate

Published:2011-04-05 Issue:13 Volume:123 Page:1436-1450
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Hankey Graeme J.¹,Eikelboom John W.¹

Affiliation:

1. From the Stroke Unit, Department of Neurology, Royal Perth Hospital, Perth, Australia (G.J.H.), and Department of Medicine, McMaster University, Hamilton, Ontario, Canada (J.W.E.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.110.004424

Reference74 articles.

1. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

2. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends

3. Warfarin, Aspirin, or Both after Myocardial Infarction

4. New Anticoagulants for Treatment of Venous Thromboembolism

5. Pharmacology and Management of the Vitamin K Antagonists

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis;Journal of Internal Medicine;2024-09-02

2. Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis;Scandinavian Journal of Clinical and Laboratory Investigation;2024-07

3. Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site;Research and Practice in Thrombosis and Haemostasis;2024-05

4. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease;Nature Reviews Cardiology;2024-03-20

5. Structural properties of newly 4,7-dihydroxycoumarin derivatives as potential inhibitors of XIIa, Xa, IIa factors of coagulation;Journal of Molecular Structure;2024-02